Serum peptidome patterns of colorectal cancer based on magnetic bead separation and MALDI-TOF mass spectrometry analysis

Journal of Biomedicine and Biotechnology

Volumn 2012, Issue , 2012, Pages

  Fan, Nai Jun ^a   Gao, Chun Fang ^a   Wang, Xiu Li ^a   Zhao, Guang ^a   Liu, Qing Yin ^a   Zhang, Yuan Yao ^a   Cheng, Bao Guo ^b  

^a The 150th Central Hospital of People's Liberation Army   (China)

^b HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; PEPTIDE; PLASMA PROTEIN; PROTEOME; TUMOR MARKER; TUMOR PROTEIN;

ADULT; ALGORITHM; ARTICLE; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROTEOMICS; SEPARATION TECHNIQUE; STOMACH CARCINOMA; VOLUNTEER; BLOOD; COLORECTAL TUMOR; IMMUNOMAGNETIC SEPARATION; METHODOLOGY; MIDDLE AGED; PEPTIDE MAPPING;

BLOOD PROTEINS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOMAGNETIC SEPARATION; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PEPTIDE MAPPING; PEPTIDES; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 84871833875     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2012/985020     Document Type: Article

References (36)

1. Jemal A., Bray F., Center M. M., Ferlay J., Ward E., Forman D., Global cancer statistics. CA Cancer Journal for Clinicians 2011 61 2 69 90 2-s2.0-79952232216 10.3322/caac.20107
2. Jemal A., Siegel R., Xu J., Ward E., Cancer statistics, 2010. CA Cancer Journal for Clinicians 2010 60 5 277 300 2-s2.0-77955635233 10.3322/caac.20073
3. Ciccolallo L., Capocaccia R., Coleman M. P., Berrino F., Coebergh J. W. W., Damhuis R. A. M., Faivre J., Martinez-Garcia C., Møller H., Ponz De Leon M., Launoy G., Raverdy N., Williams E. M. I., Gatta G., Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut 2005 54 2 268 273 2-s2.0-19944433409 10.1136/gut.2004.044214 (Pubitemid 40139245)
4. Edwards B. K., Ward E., Kohler B. A., Eheman C., Zauber A. G., Anderson R. N., Jemal A., Schymura M. J., Lansdorp-Vogelaar I., Seeff L. C., Van Ballegooijen M., Goede S. L., Ries L. A. G., Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010 116 3 544 573 2-s2.0-76249089855 10.1002/cncr.24760
5. Smith R. A., Cokkinides V., Brooks D., Saslow D., Shah M., Brawley O. W., Cancer screening in the United States, 2011: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer Journal for Clinicians 2011 61 1 8 30 2-s2.0-79951834315 10.3322/caac.20096
6. Phizicky E., Bastiaens P. I. H., Zhu H., Snyder M., Fields S., Protein analysis on a proteomic scale. Nature 2003 422 6928 208 215 2-s2.0-0037435022 10.1038/nature01512 (Pubitemid 36362758)
7. Issaq H. J., Xiao Z., Veenstra T. D., Serum and plasma proteomics. Chemical Reviews 2007 107 8 3601 3620 2-s2.0-34548324770 10.1021/cr068287r (Pubitemid 47333550)
8. Dai Y., Hu C., Wang L., Huang Y., Zhang L., Xiao X., Tan Y., Serum peptidome patterns of human systemic lupus erythematosus based on magnetic bead separation and MALDI-TOF mass spectrometry analysis. Scandinavian Journal of Rheumatology 2010 39 3 240 246 2-s2.0-77951789501 10.3109/03009740903456292
9. Petricoin E. F., Belluco C., Araujo R. P., Liotta L. A., The blood peptidome: a higher dimension of information content for cancer biomarker discovery. Nature Reviews Cancer 2006 6 12 961 967 2-s2.0-33845267469 10.1038/nrc2011 (Pubitemid 44862680)
10. Liu L. H., Shan B. E., Tian Z. Q., Sang M. X., Ai J., Zhang Z. F., Meng J., Zhu H., Wang S. J., Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clinical Chemistry and Laboratory Medicine 2010 48 6 855 861 2-s2.0-77953212672 10.1515/CCLM.2010.138
11. Sui W., Huang L., Dai Y., Chen J., Yan Q., Huang H., Proteomic profiling of renal allograft rejection in serum using magnetic bead-based sample fractionation and MALDI-TOF MS. Clinical and Experimental Medicine 2010 10 4 259 268 2-s2.0-78049331682 10.1007/s10238-010-0094-5
12. Koomen J. M., Li D., Xiao L. C., Liu T. C., Coombes K. R., Abbruzzese J., Kobayashi R., Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery. Journal of Proteome Research 2005 4 3 972 981 2-s2.0-20844448187 10.1021/pr050046x (Pubitemid 40863287)
13. Villanueva J., Philip J., Entenberg D., Chaparro C. A., Tanwar M. K., Holland E. C., Tempst P., Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Analytical Chemistry 2004 76 6 1560 1570 2-s2.0-1542617944 10.1021/ac0352171 (Pubitemid 38338398)
14. Omenn G. S., The Human Proteome Organization Plasma Proteome Project pilot phase: reference specimens, technology platform comparisons, and standardized data submissions and analyses. Proteomics 2004 4 5 1235 1240 2-s2.0-1642579024 10.1002/pmic.200300686 (Pubitemid 38648012)
15. Yao N., Chen H., Lin H., Deng C., Zhang X., Enrichment of peptides in serum by C8-functionalized magnetic nanoparticles for direct matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis. Journal of Chromatography A 2008 1185 1 93 101 2-s2.0-39649097157 10.1016/j.chroma.2008. 01.047
16. Whiteaker J. R., Zhao L., Zhang H. Y., Feng L. C., Piening B. D., Anderson L., Paulovich A. G., Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers. Analytical Biochemistry 2007 362 1 44 54 2-s2.0-33846665857 10.1016/j.ab.2006.12.023 (Pubitemid 46198803)
17. West-Nørager M., Kelstrup C. D., Schou C., Høgdall E. V., Høgdall C. K., Heegaard N. H. H., Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics. Journal of Chromatography B 2007 847 1 30 37 2-s2.0-33846813746 10.1016/j.jchromb.2006. 09.048 (Pubitemid 46216199)
18. Shin S., Cazares L., Schneider H., Mitchell S., Laronga C., Semmes O. J., Perry R. R., Drake R. R., Serum biomarkers to differentiate benign and malignant mammographic lesions. Journal of the American College of Surgeons 2007 204 5 1065 1071 2-s2.0-34247479930 10.1016/j.jamcollsurg.2007.01.036 (Pubitemid 46661204)
19. Baumann S., Ceglarek U., Fiedler G. M., Lembcke J., Leichtle A., Thiery J., Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clinical Chemistry 2005 51 6 973 980 2-s2.0-19644386500 10.1373/clinchem.2004.047308 (Pubitemid 40740877)
20. Compton C. C., Greene F. L., The staging of colorectal cancer: 2004 and beyond. Ca-A Cancer Journal for Clinicians 2004 54 6 295 308 2-s2.0-11344286311 (Pubitemid 40073988)
21. Ketterlinus R., Hsieh S. Y., Teng S. H., Lee H., Pusch W., Fishing for biomarkers: analyzing mass spectrometry data with the new ClinProTools software. BioTechniques 2005 supplement 37 40 2-s2.0-33645507259
22. Swets J. A., Measuring the accuracy of diagnostic systems. Science 1988 240 4857 1285 1293 2-s2.0-0023890867
23. Zethelius B., Berglund L., Sundström J., Ingelsson E., Basu S., Larsso A., Venge P., Ärnlöv J., Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. The New England Journal of Medicine 2008 358 20 2107 2116 2-s2.0-43549117072 10.1056/NEJMoa0707064 (Pubitemid 351679597)
24. Tolson J. P., Flad T., Gnau V., Dihazi H., Hennenlotter J., Beck A., Mueller G. A., Kuczyk M., Mueller C. A., Differential detection of S100A8 in transitional cell carcinoma of the bladder by pair wise tissue proteomic and immunohistochemical analysis. Proteomics 2006 6 2 697 708 2-s2.0-32144462497 10.1002/pmic.200500033 (Pubitemid 43208048)
25. Cheng A. J., Chen L. C., Chien K. Y., Chen Y. J., Chang J. T. C., Wang H. M., Liao C. T., Chen I. H., Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology. Clinical Chemistry 2005 51 12 2236 2244 2-s2.0-28044447188 10.1373/clinchem.2005.052324 (Pubitemid 41692565)
26. Alagaratnam S., Mertens B. J. A., Dalebout J. C., Deelder A. M., Van Ommen G. J. B., Den Dunnen J. T., 'T Hoen P. A. C., Serum protein profiling in mice: identification of Factor XIIIa as a potential biomarker for muscular dystrophy. Proteomics 2008 8 8 1552 1563 2-s2.0-42549137898 10.1002/pmic. 200700857 (Pubitemid 351580202)
27. Chinello C., Gianazza E., Zoppis I., Mainini V., Galbusera C., Picozzi S., Rocco F., Galasso G., Bosari S., Ferrero S., Perego R., Raimondo F., Bianchi C., Pitto M., Signorini S., Brambilla P., Mocarelli P., Galli Kienle M., Magni F., Serum biomarkers of renal cell carcinoma assessed using a protein profiling approach based on ClinProt technique. Urology 2010 75 4 842 847 2-s2.0-77950370536 10.1016/j.urology.2009.09.050
28. Du J., Yang S., Lin X., Bu L., Nan Y., Huo S., Shang W., Use of anchorchip-time-of-flight spectrometry technology to screen tumor biomarker proteins in serum for small cell lung cancer. Diagnostic Pathology 2010 5, article 60 2-s2.0-77956633075 10.1186/1746-1596-5-60
29. Ikonomou G., Samiotaki M., Panayotou G., Proteomic methodologies and their application in colorectal cancer research. Critical Reviews in Clinical Laboratory Sciences 2009 46 5-6 319 342 2-s2.0-71849104219 10.3109/ 10408360903375277
30. Petricoin E. F., Ardekani A. M., Hitt B. A., Levine P. J., Fusaro V. A., Steinberg S. M., Mills G. B., Simone C., Fishman D. A., Kohn E. C., Liotta L. A., Use of proteomic patterns in serum to identify ovarian cancer. The Lancet 2002 359 9306 572 577 2-s2.0-0037116832 10.1016/S0140-6736(02)07746-2 (Pubitemid 34178440)
31. Chen Y. D., Zheng S., Yu J. K., Hu X., Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population. Clinical Cancer Research 2004 10 24 8380 8385 2-s2.0-11144233952 10.1158/1078-0432.CCR-1162-03 (Pubitemid 40053400)
32. Liu X. P., Shen J., Li Z. F., Yan L., Gu J., A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry. Cancer Investigation 2006 24 8 747 753 2-s2.0-33845642036 10.1080/07357900601063873 (Pubitemid 44949879)
33. Fan N.-J., Gao C.-F., Wang X.-L., Identification of regional lymph node involvement of colorectal cancer by serum SELDI proteomic patterns. Gastroenterology Research and Practice 2011 2011 6 784967 2-s2.0-84855581128 10.1155/2011/784967
34. Hortin G. L., The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome. Clinical Chemistry 2006 52 7 1223 1237 2-s2.0-33745442821 10.1373/clinchem.2006.069252 (Pubitemid 43956011)
35. Navare A., Zhou M., McDonald J., Noriega F. G., Sullards M. C., Fernandez F. M., Serum biomarker profiling by solid-phase extraction with particle-embedded micro tips and matrix-assisted laser desorption/ionization mass spectrometry. Rapid Communications in Mass Spectrometry 2008 22 7 997 1008 2-s2.0-41549165737 10.1002/rcm.3462 (Pubitemid 351468255)
36. Cho W. C. S., Contribution of oncoproteomics to cancer biomarker discovery. Molecular Cancer 2007 6, article 25 2-s2.0-34247282875 10.1186/1476-4598-6-25 (Pubitemid 46605013)